Pharmaceutical composition for treatment and prevention of diseases involving impotence
KR20070074538A
Pharmaceutical composition for the treatment or prevention of diseases involving obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases
KR20070082557A
Method for controlling nad(p)/nad(p)h ratio by oxidoreductase
KR20070055952A
Composition having effect on treatment and prevention of dry eye syndrome
KR20070044198A
Anti-metabolic syndrome treatment with fumaric acid and fumaric acid derivatives
KR20060081526A
Treatment of prostate diseases with zinc aspartate chelate
CN1901900A
Obesity and metabolic syndrome treatment with tanshinone derivatives which increase metabolic activity
KR20050111667A
Soybean extract of enhancing biosynthesis of hyaluronic acid and glycosaminoglycan
KR20050111670A
Uridine and uridine derivatives of enhancing biosynthesis of hyaluronic acid, glycosaminoglycan and/or collagen
KR20050111658A
Anti-obesity treatment with angelica species extracts
KR20050111669A
Gallate and gallate derivatives of enhancing biosynthesis of hyaluronic acid, glycosaminoglycan and/or collagen
KR20050111657A
Anti-diabets treatment with angelica species extracts
KR20050082447A
Diabete treatment with tetrahydroberberine
KR20050082448A
Arterioclerosis, hyperlipidmia and liver disease treatment with tertrahydroberberine
KR20050082446A
Obesity treatment with tetrahydroberberine
KR20050072275A
Diabete treatment with forsythiae fructus
KR20050058530A
Screening method for screening active compounds or natural extracts having activatory effects on 5' amp-activated protein kinase
KR20050007997A
Active fraction having weight loss effects on Leprdb/Leprdb mice isolated from medicinal plants
KR20050007996A
Compositions for arthritis disease
KR20050005633A
Lonicera japonica extract having activity of growth hormone secretagogue, its process method, and application
